A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials.

CONCLUSIONS: Tolvaptan has been used safely in combination with statins in clinical trials.
PMID: 32241780 [PubMed - as supplied by publisher]

Source: Clinical Journal of the American Society of Nephrology : CJASN - April 1, 2020 Category: Urology & Nephrology Authors: Shoaf SE, Ouyang J, Sergeyeva O, Estilo A, Li H, Leung D Tags: Clin J Am Soc Nephrol Source Type: research